EFFICACY COMPARISON OF ACITRETIN VERSUS NARROW BAND ULTRAVIOLET B IN THE TREATMENT OF PSORIASIS
DOI:
https://doi.org/10.60127/sjms.v1i4.16Keywords:
Psoriasis, Narrow Band Ultraviolet-B, AcitretinAbstract
To compare the efficacy of Acitretin versus Narrow Band Ultraviolet B in the treatment of chronic Psoriasis This randomized clinical trial was carried out at the department of dermatology DHQ Sargodha Hospital from Dec 2021 to Dec 2022. After getting approval from the Ethical review committee, 80 psoriasis patients were selected. They were suffering from moderate to severe plaque psoriasis. They were divided into two groups of 40 each. Group A patients received acitretin while Group B patients received Narrow Band Ultraviolet B for 6 weeks. Efficacy end point was decided to be PASI 50. In group A, 82%patients achieved PASI 50 while in Group B 39% patients achieved PASI 50 . The efficacy of acitretin was significantly higher than that of Narrow Band Ultraviolet B: Acitretin is a useful treatment modality for the treatment of moderate & severe plaque psoriasis.
Downloads
Published
Issue
Section
License
Authors retain the copyright to their work and grant the Sial Journal of Medical Sciences the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
